The Trump administration announced a rebrand of the US Artificial Intelligence (AI) Safety Institute, stripping the word “safety” from…
Investing
-
-
Investing
Crypto Market Recap: Strategy Eyes US$1B Raise for Bitcoin Push, UK Regulator Reverses ETN Ban
Here’s a quick recap of the crypto landscape for Wednesday (June 4) as of 9:00 p.m. UTC. Get the…
-
Investing
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen’s North American Expansion
US Capital Global Securities LLC, the SEC-registered broker-dealer division of the global private financial group US Capital Global is…
-
Investing
Crypto Market Recap: DePIN Market expected to soar, Hong Kong seeks to expand its digital asset market
Here’s a quick recap of the crypto landscape for Wednesday (June 4) as of 9:00 p.m. UTC. Get the…
-
Investing
Red Metal Resources Provides Update on Results of Mapping Program on Its Carrizal IOCG Property
Red Metal Resources Ltd. (CSE: RMES) (OTC Pink: RMESF) (FSE: I660) (‘Red Metal’ or the ‘Company’) is pleased to announce it has…
-
Bold Ventures Inc. (TSXV: BOL) (the ‘Company’ or ‘Bold’) is pleased to announce that the offering of its non-brokered private placement first…
-
(TheNewswire) Vancouver, British Columbia TheNewswire – June 5th, 2025 Prismo Metals Inc. (the ‘ Company ‘) (CSE: PRIZ) (OTCQB:…
-
Investing
Metals Focus: Gold to Average US$3,210 in 2025 as Central Banks Buy and Trade Tensions Grow
Leading gold analysis firm Metals Focus published its annual flagship Gold Focus report on Thursday (June 5). The report outlines…
-
Investing
Charbone Hydrogene a execute un financement de 50 millions USD pour accelerer son expansion en hydrogene en Amerique du Nord, facilite par US Capital Global
(TheNewswire) Un groupe financier privé mondial dont le siège social est à San Francisco conseille sur la facilité de…
-
Investing
Radiopharm Theranostics Doses First Patient in Phase 1 ‘HEAT’ Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors
Phase 1 1 First-In-Human study designed to assess safety , tolerability , right dose for Phase…